| Plasma Cell Myeloma |
32.3% |
| Multiple Sclerosis |
19.5% |
| Product Used For Unknown Indication |
8.2% |
| Myelodysplastic Syndrome |
7.7% |
| Immunodeficiency Common Variable |
4.6% |
| Prostate Cancer Metastatic |
3.6% |
| Relapsing-remitting Multiple Sclerosis |
3.6% |
| Gait Disturbance |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Chronic Myeloid Leukaemia |
2.1% |
| Colorectal Cancer Metastatic |
1.5% |
| Depression |
1.5% |
| Narcolepsy |
1.5% |
| Systemic Lupus Erythematosus |
1.5% |
| 5Q Minus Syndrome |
1.0% |
| Blood Pressure |
1.0% |
| Blood Pressure Increased |
1.0% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Gastrointestinal Stromal Tumour |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
